AVROBIO, Inc. Contracts & Agreements
69 Contracts & Agreements
- Business Finance (13 contracts)
- Business Operations (3)
- Human Resources (35)
- Intellectual Property (9)
- Mergers & Acquisitions (1)
- Real Estate (1)
- Uncategorized (7)
- Non-Employee Director Compensation Policy of Tectonic Therapeutic, Inc (Filed With SEC on November 12, 2024)
- Separation Agreement, dated July 5, 2024, between Tectonic Therapeutic, Inc. and Christian Cortis (Filed With SEC on July 5, 2024)
- Tectonic Therapeutic, Inc. 2024 Equity Incentive Plan (Filed With SEC on June 20, 2024)
- Amended and Restated Employment Agreement, dated as of June 20, 2024, by and between Tectonic Therapeutic, Inc. and Alise Reicin, M.D (Filed With SEC on June 20, 2024)
- Subscription Agreement, dated as of January 30, 2024, by and among Tectonic and the purchasers thereunder (Filed With SEC on June 20, 2024)
- Form of Indemnification Agreement between Tectonic Therapeutic, Inc. and each of its directors and executive officers (Filed With SEC on June 20, 2024)
- Contingent Value Rights Agreement dated June 20, 2024, by and between Tectonic Therapeutic, Inc. and Computershare Trust Company, LLC (Filed With SEC on June 20, 2024)
- Forms of Option Grant Notice, Option Agreement and Notice of Exercise under Tectonic Therapeutic, Inc. 2024 Equity Incentive Plan (Filed With SEC on June 20, 2024)
- Tectonic Therapeutic, Inc. 2024 Employee Stock Purchase Plan (Filed With SEC on June 20, 2024)
- Employment Agreement, by and between AVROBIO, Inc. and Azadeh Golipour, dated January 26, 2022 (Filed With SEC on February 14, 2024)
- Employee Relocation and Transition Benefits Agreement, by and between AVROBIO, Inc. and Azadeh Golipour, dated January 31, 2022 (Filed With SEC on February 14, 2024)
- Consulting Agreement, dated September 25, 2019, by and between Tectonic Therapeutic, Inc. and Andrew Kruse (Filed With SEC on February 14, 2024)
- 2019 Equity Incentive Plan of Tectonic Therapeutic, Inc (Filed With SEC on February 14, 2024)
- Amendment to 2019 Equity Incentive Plan of Tectonic Therapeutic, Inc (Filed With SEC on February 14, 2024)
- Form of Lock-Up Agreement (Filed With SEC on January 30, 2024)
- Form of Contingent Value Rights Agreement (Filed With SEC on January 30, 2024)
- Form of AVRO Support Agreement (Filed With SEC on January 30, 2024)
- Form of Tectonic Support Agreement (Filed With SEC on January 30, 2024)
- Agreement and Plan of Merger, dated as of January 30, 2024, by and among AVRO, Aspen Merger Subsidiary, Inc. and Tectonic (Filed With SEC on January 30, 2024)
- Amended and Restated Master Services Agreement, by and between the Registrant and Miltenyi Biotec, Inc., dated November 20, 2021 (Filed With SEC on August 9, 2022)
- Second Amendment to the AVROBIO, Inc. 2018 Stock Option and Incentive Plan (Filed With SEC on June 10, 2022)
- AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (Filed With SEC on May 10, 2022)
- Employment Agreement, by and between the Registrant and Essra Ridha, dated October 6, 2021 (Filed With SEC on March 17, 2022)
- Loan and Security Agreement, dated November 2, 2021, by and among the Registrant, the lenders party thereto from time to time and Silicon Valley Bank, as administrative agent and... (Filed With SEC on November 4, 2021)
- Amendment to Employment Agreement, by and between the Registrant and Diana Escolar, MD, dated April 5, 2021 (Filed With SEC on May 13, 2021)
- Amendment to Employment Agreement, by and between the Registrant and Chris Mason, dated April 5, 2021 (Filed With SEC on May 13, 2021)
- Amendment to Employment Agreement, by and between the Registrant and Deanna Petersen, dated April 5, 2021 (Filed With SEC on May 13, 2021)
- Amendment to Employment Agreement, by and between the Registrant and Erik Ostrowski, dated April 5, 2021 (Filed With SEC on May 13, 2021)
- Amendment to Employment Agreement, by and between the Registrant and Geoff MacKay, dated April 5, 2021 (Filed With SEC on May 13, 2021)
- Amendment to Employment Agreement, by and between the Registrant and Steven Avruch, dated April 5, 2021 (Filed With SEC on May 13, 2021)
- Employment Agreement, by and between the Registrant and Diana Escolar, dated December 4, 2020 (Filed With SEC on March 18, 2021)
- Employment Agreement, by and between the Registrant and Chris Mason, dated September 1, 2018 (Filed With SEC on March 18, 2021)
- 2020 Inducement Plan and form of award agreement thereunder (Filed With SEC on March 18, 2021)
- Underwriting Agreement, dated November 19, 2020, between AVROBIO, Inc. Morgan Stanley & Co. LLC and Cowen and Company, LLC, as representatives of the several underwriters named... (Filed With SEC on November 20, 2020)
- Separation Agreement and Release, by and between the Registrant and Birgitte Volck, M.D., Ph.D., dated July 16, 2020 (Filed With SEC on August 6, 2020)
- First Amendment to the AVROBIO, Inc. 2018 Stock Option and Incentive Plan (Filed With SEC on June 9, 2020)
- Employment Agreement, by and between the Registrant and Deanna Petersen, dated September 1, 2018 (Filed With SEC on March 16, 2020)
- Amendment No. 2 to License Agreement, by and between the Registrant and BioMarin Pharmaceutical Inc., dated January 7, 2020 (Filed With SEC on March 16, 2020)
- Amendment No. 1 to License Agreement, by and between the Registrant and BioMarin Pharmaceutical Inc., dated February 21, 2018 (Filed With SEC on March 16, 2020)
- Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 16, 2020)
- Underwriting Agreement, dated February 12, 2020, between AVROBIO, Inc., and Morgan Stanley & Co. LLC and Cowen and Company, LLC, as representatives of the several underwriters... (Filed With SEC on February 13, 2020)
- Underwriting Agreement, dated July 16, 2019, between AVROBIO, Inc. Morgan Stanley & Co. LLC and Cowen and Company, LLC, as representatives of the several underwriters named therein (Filed With SEC on July 17, 2019)
- Consulting Agreement, by and between the Registrant and Birgitte Volck, M.D., Ph.D., dated December 17, 2018 (Filed With SEC on March 25, 2019)
- Employment Agreement, by and between the Registrant and Steven Avruch, dated December 17, 2018 (Filed With SEC on March 25, 2019)
- Employment Agreement, by and between the Registrant and Birgitte Volck, M.D., Ph.D., dated December 17, 2018 (Filed With SEC on March 25, 2019)
- Separation Agreement and Release, dated January 8, 2019, by and between the Company and Katina Dorton (Filed With SEC on January 11, 2019)
- Separation Agreement and Release, dated January 10, 2019, by and between the Company and Nerissa Kreher, M.D (Filed With SEC on January 11, 2019)
- Employment Agreement, dated December 17, 2018, by and between the Company and Erik Ostrowski (Filed With SEC on December 21, 2018)
- License Agreement, by and between the Registrant and BioMarin Pharmaceutical Inc., dated August 31, 2017 (Filed With SEC on June 11, 2018)
- Form of Underwriting Agreement (Filed With SEC on June 11, 2018)
- Form of Specimen Common Stock Certificate (Filed With SEC on June 11, 2018)
- 2018 Stock Option and Incentive Plan and forms of award agreements thereunder (to be effective upon the effectiveness of this registration statement) (Filed With SEC on June 11, 2018)
- Senior Executive Cash Incentive Bonus Plan (Filed With SEC on June 11, 2018)
- Form of Indemnification Agreement (Filed With SEC on June 11, 2018)
- Amended and Restated Employment Agreement, by and between the Registrant and Geoff MacKay (to be effective upon the closing of this offering) (Filed With SEC on June 11, 2018)
- Amended and Restated Employment Agreement, by and between the Registrant and Nerissa Kreher, M.D. (to be effective upon the closing of this offering) (Filed With SEC on June 11, 2018)
- Amended and Restated Employment Agreement, by and between the Registrant and Katina Dorton (to be effective upon the closing of this offering) (Filed With SEC on June 11, 2018)
- 2018 Employee Stock Purchase Plan (to be effective upon the effectiveness of this registration statement) (Filed With SEC on June 11, 2018)
- License Agreement, by and between the Registrant and BioMarin Pharmaceutical Inc., dated August 31, 2017 (Filed With SEC on June 1, 2018)
- Exclusive License Agreement, by and between the Registrant and University Health Network, dated November 4, 2016, as amended (Filed With SEC on June 1, 2018)
- 2015 Amended and Restated Stock Option and Grant Plan, as amended, and forms of award agreements thereunder (Filed With SEC on May 25, 2018)
- Second Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, dated January 9, 2018 (Filed With SEC on May 25, 2018)
- Warrant to Purchase Stock issued to Silicon Valley Bank, dated June 23, 2017 (Filed With SEC on May 25, 2018)
- Loan and Security Agreement, by and among the Registrant and Silicon Valley Bank, dated June 23, 2017 (Filed With SEC on May 25, 2018)
- Lease Agreement, dated as of January 12, 2018, by and between the Registrant and ARE-MA Region No. 59, LLC (Filed With SEC on May 25, 2018)
- License Agreement, by and between the Registrant and GenStem Therapeutics, Inc., dated October 2, 2017 (Filed With SEC on May 25, 2018)
- Exclusive License Agreement, by and among the Registrant, Stefan Karlsson and Maria Dahl, dated January 30, 2017 (Filed With SEC on May 25, 2018)
- License Agreement, by and between the Registrant and BioMarin Pharmaceutical Inc., dated August 31, 2017 (Filed With SEC on May 25, 2018)
- Exclusive License Agreement, by and between the Registrant and University Health Network, dated November 4, 2016, as amended (Filed With SEC on May 25, 2018)
